ArticlePloS one2024

Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.

Fanny Porte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.